sildenafil-citrate and Pancreatitis

sildenafil-citrate has been researched along with Pancreatitis* in 1 studies

Other Studies

1 other study(ies) available for sildenafil-citrate and Pancreatitis

ArticleYear
Effects of sildenafil on inflammatory injury of the lung in sodium taurocholate-induced severe acute pancreatitis rats.
    International immunopharmacology, 2020, Volume: 80

    Inflammatory response and acute lung injury (ALI) occur in sodium taurocholate-induced severe acute pancreatitis (SAP). Because sildenafil has anti-inflammatory, anti-oxidant and immune-modulating effects, we investigated its effect on inflammatory and lung injury in sodium taurocholate-induced SAP-associated ALI rat lung.. Sodium taurocholate-induced SAP rats received sildenafil (100 mg/kg) or not and were compared to age-matched normal control animals. We evaluated inflammatory response by detecting the expression of inflammatory factors including IL-1β, IL-6 and TNF-α, and detected the level of lung injury through histopathological evaluation. Moreover, we also tested the protein expression of PCNA, P21, Bcl-2 and Bax in the lung.. Sildenafil administration rats had a low level of lung injury and inflammation. In addition, sildenafil significantly increased the expression of proliferation-related markers and decreased the expression of apoptosis-related markers in lung tissue.. Sildenafil administration may attenuate inflammation and lung injury by promoting proliferation and suppressing apoptosis in SAP rats.

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Lung; Male; Pancreas; Pancreatitis; Rats, Sprague-Dawley; Sildenafil Citrate; Taurocholic Acid

2020